Author Insight: Cancer Drug Prices in Low- and Middle-Income Countries

4 views

|

February 15, 2022

Dr. Bishal Gyawali from the Institute of Cancer Policy, London and Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital, discusses his editorial that was published by Oncotarget in Volume 8, Issue 52, entitled, “Cancer drugs in LMICs: cheap but unaffordable.” DOI - https://doi.org/10.18632/oncotarget.21976 (PDF download) Full text - https://www.oncotarget.com/article/21976/ Correspondence to - Bishal Gyawali - bg.bishalgyawali@gmail.com; @oncology_bg Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.21976 Keywords - value, affordability, global oncology, drug prices, cancer About Oncotarget Oncotarget is a peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - https://soundcloud.com/oncotarget Facebook - https://www.facebook.com/Oncotarget/ Twitter - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/c/OncotargetYouTube/ LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Oncotarget is published by Impact Journals, LLC: https://www.ImpactJournals.com Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

BiopharmaCancer ResearchChemistryDrug Discovery

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.